Projected Income Statement: Stryker Corporation

Forecast Balance Sheet: Stryker Corporation

Forecast Balance Sheet - Stryker Corporation
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 9,453 9,929 7,879 7,695 11,848 9,614 6,368 2,605
Change - 5.04% -20.65% -2.34% 53.97% -18.86% -33.76% -59.09%
Announcement Date 1/27/22 1/31/23 1/30/24 1/28/25 1/29/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Stryker Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 525 588 575 755 761 867.3 910.1 945.2
Change - 12% -2.21% 31.3% 0.79% 13.97% 4.93% 3.86%
Free Cash Flow (FCF) 1 2,738 2,036 3,105 3,487 4,283 4,137 5,111 5,800
Change - -25.64% 52.5% 12.3% 22.83% -3.4% 23.54% 13.47%
Announcement Date 1/27/22 1/31/23 1/30/24 1/28/25 1/29/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Stryker Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 27.78% 25.77% 26.09% 27.18% 28.13% 29.23% 28.49% 29.56%
EBIT Margin (%) 25.61% 23.76% 24.17% 25.29% 26.29% 26.75% 26.56% 27.58%
EBT Margin (%) 13.33% 14.54% 17.92% 15.45% 17.97% 20.87% 22.77% 23.82%
Net margin (%) 11.66% 12.78% 15.44% 13.25% 12.92% 16.89% 18.84% 19.86%
FCF margin (%) 16% 11.04% 15.15% 15.43% 17.05% 15.43% 17.47% 18.82%
FCF / Net Income (%) 137.31% 86.34% 98.1% 116.51% 131.95% 91.39% 92.75% 94.78%

Profitability

        
ROA 10.08% 9.99% 10.59% 11.34% 11.6% 10.84% 11.7% 11.97%
ROE 24.85% 22.68% 23.1% 23.96% 24.47% 23.57% 22.75% 21.42%

Financial Health

        
Leverage (Debt/EBITDA) 1.99x 2.09x 1.47x 1.25x 1.68x 1.23x 0.76x 0.29x
Debt / Free cash flow 3.45x 4.88x 2.54x 2.21x 2.77x 2.32x 1.25x 0.45x

Capital Intensity

        
CAPEX / Current Assets (%) 3.07% 3.19% 2.81% 3.34% 3.03% 3.24% 3.11% 3.07%
CAPEX / EBITDA (%) 11.05% 12.37% 10.75% 12.29% 10.77% 11.07% 10.92% 10.37%
CAPEX / FCF (%) 19.17% 28.88% 18.52% 21.65% 17.77% 20.96% 17.81% 16.3%

Items per share

        
Cash flow per share 1 8.535 6.866 9.591 11 13.05 12.25 15.78 20.22
Change - -19.56% 39.7% 14.7% 18.63% -6.1% 28.77% 28.16%
Dividend per Share 1 2.585 2.835 3.05 3.24 3.4 3.624 3.817 4.099
Change - 9.67% 7.58% 6.23% 4.94% 6.59% 5.32% 7.39%
Book Value Per Share 1 39.41 43.93 48.98 54.16 58.66 66.97 77.23 89.61
Change - 11.48% 11.49% 10.57% 8.31% 14.16% 15.32% 16.04%
EPS 1 5.21 6.17 8.25 7.76 8.4 11.65 13.86 15.98
Change - 18.43% 33.71% -5.94% 8.25% 38.72% 18.92% 15.34%
Nbr of stocks (in thousands) 377,240 378,430 379,938 381,216 382,424 380,691 380,691 380,691
Announcement Date 1/27/22 1/31/23 1/30/24 1/28/25 1/29/26 - - -
1USD
Estimates
2026 *2027 *
P/E 25x 21.1x
PBR 4.36x 3.78x
EV / Sales 4.5x 4.02x
Yield 1.24% 1.31%

EPS & Dividend

EPS & Dividend - Stryker Corporation


Y-o-Y evolution of P/E

Valuation ratios - P/E - Stryker Corporation
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Stryker Corporation
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Stryker Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
291.86USD
Average target price
341.37USD
Spread / Average Target
+16.96%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Stryker Corporation
  1. Stock Market
  2. Stocks
  3. SYK Stock
  4. Financials Stryker Corporation